Inactive Instrument

News Actelion CBOE EUROPE EQUITIES

Equities

ATLN

CH0010532478

End-of-day quote CBOE EUROPE EQUITIES Other stock markets
- ^CHF	-

2017	Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	RE
2017	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents	06/04/20	AQ
Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017	31/10/17	GL
Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	31/07/17	RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	18/07/17	RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	18/07/17	RE
Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung	30/06/17	GL
Actelion : Johnson & Johnson Completes Acquisition of Actelion	16/06/17	GL
Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	15/06/17	PU
Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson	14/06/17	GL
Spin off	13/06/17	FA
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	09/06/17	RE
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	09/06/17	RE
Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16	09/06/17	RE
Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	09/06/17	GL
Actelion : Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017	09/06/17	GL
Actelion : provides an update on the Phase III IMPACT program with cadazolid in CDAD	08/06/17	GL
Akzo Nobel : Cross-border M&A between U.S. and European firms at 10 year high	22/05/17	RE
Actelion : provides an update on the progress towards launching Idorsia - Key results for pipeline assets to be developed by Idorsia	22/05/17	GL
Actelion : Johnson & Johnson offers EU concessions over Actelion deal	18/05/17	RE
Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson	15/05/17	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Actelion CBOE EUROPE EQUITIES

Equities

ATLN

CH0010532478

Summary

Filters